Literature DB >> 27600194

Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes.

Marta Castro-Rodríguez1, José A Carnicero2, Francisco J Garcia-Garcia3, Stephan Walter2, John E Morley4, Fernando Rodríguez-Artalejo5, Alan J Sinclair6, L Rodríguez-Mañas7.   

Abstract

OBJECTIVES: To assess the role of frailty in predicting death and incident disability in older adults with type 2 diabetes mellitus.
DESIGN: Prospective cohort study.
SETTING: Community dwelling. PARTICIPANTS: A total of 1825 individuals ≥65 years old recruited between June 2006 and September 2009 were followed for a median of 5.5 years for mortality and 4.98 years for incident functional disability in activities of daily living. Self-reported diabetes, comorbidities (Charlson index), cardio- and cerebrovascular diseases, drug treatments, Frailty Trait Score (FTS) and Frailty Index (FI), activities of daily living, heart rate, and blood pressure among others were collected at baseline. MAIN OUTCOME MEASURES: Survival analysis (Kaplan-Meier), adjusted Cox proportional-hazards models, and binary logistic regression were used to assess the relationship between frailty, comorbidity, and vascular diseases and time to death and incident disability.
RESULTS: A total of 363 people had diabetes. Among them, 83 deaths and 84 cases of incident disability occurred during follow-up. People with diabetes died more frequently than those without diabetes [hazard ratio = 1.36, 95% confidence interval (CI) 1.06-1.75; P = .002], showing a poorer functional status at baseline. Survival analysis showed a relationship between frailty quartiles and the risk of death. In the adjusted Cox-models, only age and frailty indices, but not comorbidity or cardio/cerebrovascular diseases, were associated with the risk of death and incident disability after adjusting for measures of frailty. The hazard ratio for death was 1.51 (95% CI 1.28-1.77) and 1.83 (95% CI 1.49-2·26) for each 10 points increase in the FTS and FI; odds ratio for incident disability was 1·64 (95% CI 1.22-2.20) and 1·35 (95% CI 1.09-1.67) when using FI and FTS, respectively.
CONCLUSIONS: Frailty is an important risk factor for death and disability in older adults with diabetes, supporting the recent recommendations that frailty status should be routinely assessed in these patients.
Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Older adults; disability; frailty; mortality; risk factors; type 2 diabetes

Mesh:

Year:  2016        PMID: 27600194     DOI: 10.1016/j.jamda.2016.07.013

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  31 in total

1.  Comorbidity, Frailty, and Waitlist Mortality among Kidney Transplant Candidates of All Ages.

Authors:  María Pérez Fernández; Patricia Martínez Miguel; Hao Ying; Christine E Haugen; Nadia M Chu; Diego María Rodríguez Puyol; Leocadio Rodríguez-Mañas; Silas P Norman; Jeremy D Walston; Dorry L Segev; Mara A McAdams-DeMarco
Journal:  Am J Nephrol       Date:  2019-01-09       Impact factor: 3.754

2.  Editorial: Frailty - An Emerging High Impact Complication of Diabetes Requiring Specific Management Approaches.

Authors:  A Sinclair; B Vellas
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Measures of Frailty in Chronic Lung Diseases.

Authors:  Tracy Luckhardt; Victor J Thannickal
Journal:  Ann Am Thorac Soc       Date:  2017-08

4.  Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Authors:  Josep Franch-Nadal; Fermín García-Gollarte; Alfonso Pérez Del Molino; María L Orera-Peña; Marta Rodríguez de Miguel; Malena Melogno-Klinkas; Héctor D de Paz; Susana Aceituno; Patricia Rodríguez-Fortúnez
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

5.  Frailty, Diabetes, and Mortality in Middle-Aged African Americans.

Authors:  S Chode; T K Malmstrom; D K Miller; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

6.  Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.

Authors:  Pedro Monteiro; Richard M Bergenstal; Elvira Toural; Silvio E Inzucchi; Bernard Zinman; Stefan Hantel; Sanja Giljanovic Kiš; Stefan Kaspers; Jyothis T George; David Fitchett
Journal:  Age Ageing       Date:  2019-11-01       Impact factor: 10.668

7.  Palliative and End-of-Life Care: Vital Aspects of Holistic Diabetes Care of Older People With Diabetes.

Authors:  Trisha Lynette Dunning
Journal:  Diabetes Spectr       Date:  2020-08

8.  Challenges and Strategies for Diabetes Management in Community-Living Older Adults.

Authors:  Alan J Sinclair; Ahmed H Abdelhafiz
Journal:  Diabetes Spectr       Date:  2020-08

9.  Community-Based Exercise and Lifestyle Program Improves Health Outcomes in Older Adults with Type 2 Diabetes.

Authors:  Morwenna Kirwan; Christine L Chiu; Mellissa Hay; Thomas Laing
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390

10.  Dual effects of insulin resistance on mortality and function in non-diabetic older adults: findings from the Toledo Study of Healthy Aging.

Authors:  Leocadio Rodríguez-Mañas; Javier Angulo; José A Carnicero; Mariam El Assar; Francisco J García-García; Alan J Sinclair
Journal:  Geroscience       Date:  2021-06-01       Impact factor: 7.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.